Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New family of marine natural products discovered

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Penam sulfones with beta-lactamase-inhibitory activity

Oct. 11, 1996

Antiviral/corticosteroid therapy beneficial for herpes zoster

Oct. 4, 1996

Roche and Gilead Sciences collaborate on the development of neuraminidase inhibitors

Oct. 4, 1996

Development of ViroPharma's lead antiviral drug progresses

Oct. 4, 1996

Sch-48973, a potent, broad-spectrum antienterovirus compound

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.